skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

930 Total results for product and free and sample content found

Pharmaprojects, Citeline

Pharma R&D Annual Review 2018

By Ian Lloyd 13 Mar 2018

Authored for the last 25 years by Ian Lloyd, Senior Director of Pharmaprojects and Data Integration, this vital resource uses a music motif to turn up the volume on the evolution of trends in pharmaceutical R&D. Lloyd assesses industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type.

Topic Research


Meddevicetracker Weekly Roundup 09-03-18

13 Mar 2018

In this week's Meddevicetracker weekly roundup DePuy Synthes announces agreement with SERF to add dual mobility system to its hip portfolio, Admedus receives regulatory approval to launch CardioCel 3D and VascuCel in Canada, and more.

Medtech Insight

Medtech Insights Device Week Podcast - Approvals And M&A

By David Filmore 12 Mar 2018

In this edition of Device Week, Medtech Insight’s Reed Miller, David Filmore and Catherine Longworth look back at the past year and the key trends in US and international product approvals, as well as in M&A activity. They also give their perspectives on what to look forward to in 2018.

Topic Medtech

Datamonitor Healthcare

Datamonitor Healthcare Podcast 02 March 2018

By Jack Allen 09 Mar 2018

Zach McLellan, Jack Allen, and guest analyst Dan Chancellor discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. Featuring analysis of the Sangamo Therapeutics and Gilead/Kite partnership for allogeneic oncology products & update on Restasis patent disputes.

Topic Company analysis


Opdivos EU Colorectal Cancer is a Setback but More Than Offset By Potential Gains

By Ian Schofield 05 Mar 2018

Bristol-Myers Squibb has withdrawn its EU application to extend Opdivo’s use to metastatic colorectal cancer (mCRC), following a similar move for liver cancer last year. But the mCRC withdrawal is likely to have limited commercial impact and the company is more interested in pursuing the product’s use in combination treatment for this indication.

Topic Cancer


Workforce Roundtable Part 1: Recruiting Biopharma Leaders As The Talent Pool Shrinks

By Mandy Jackson 28 Feb 2018

As Baby Boomers age out of the workforce, they'll be replaced in biopharma C-suites and boardrooms by a younger, more female and racially diverse group. A panel of current and former life science CEOs, venture investors and recruiters discuss the challenges and opportunities ahead.

Topic Business strategies

In Vivo

Repositioning Market Access: A Function Fit For Purpose In A New Era Of Costly Cures

By William Looney 28 Feb 2018

On October 5, In Vivo convened a group of top market-access specialists and industry and investment analysts to consider a central strategic challenge facing all innovators in biopharma: how to pay for the next wave of cures. Finding the answer first depends on a rebranding of the function itself – it’s not market access to products; it’s patient access to progress.

Topic Strategy

In Vivo

Curing What Hinders Alzheimer’s Drug Development

By Rachel Laing, Alessia Deglincerti, Mark Ratner 28 Feb 2018

Biomarkers will be key to winning the race to a successful AD drug. Even then, drugmakers must build the infrastructure for getting therapy to the right patients at the right time.

Topic Alzheimers Drug development landscape


Biomedtracker 2018 Early Outlook Report

27 Feb 2018

What’s on the horizon for pharma in 2018? Find out with Biomedtracker’s Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.

Topic Drug development landscape

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: